New program covers employees' cost of attendance to DPT program to address PT shortage and student debtLOUISVILLE, Ky., June 26,...
Two iconic coastal-living brands team up for a limited-edition summer beer and capsule collectionMONTAUK, N.Y., June 26, 2025 (GLOBE NEWSWIRE)...
The Independent Data Monitoring Committee (“IDMC”) has recommended to continue the study as planned as there are no safety concerns...
KNOXVILLE, Tenn., June 26, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the...
Company digitizes complex chemical logistics, helping pharmaceutical, biotech, and university R&D laboratories better manage and control their raw materialsBOSTON, June...
JERUSALEM, June 26, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides...
ASCEND comprises two dosing regimens of certepetide evaluated in two separate study arms enrolled sequentially Positive signal in progression-free survival...
MALVERN, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical...
Recognition highlights EluPro™ Antibiotic-Eluting BioEnvelope’s impact on device protection for cardiac implantable electronic devices (CIEDs) and neurostimulators SILVER SPRING, Md.,...
GREENWOOD VILLAGE, Colo., June 26, 2025 (GLOBE NEWSWIRE) -- Pure Harvest Corporate Group, Inc. (OTC: PHCG), a strategic holding company...
Certification demonstrates Liviniti's strong commitment to data security and risk managementNatchitoches, Louisiana--(Newsfile Corp. - June 26, 2025) - Liviniti, a...
Calgary, Alberta--(Newsfile Corp. - June 26, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
London, United Kingdom--(Newsfile Corp. - June 26, 2025) - Edison issues report on Lamda Development (ASE: LAMDA).LAMDA Development is the...
The American Academy of Dermatology (AAD) provided evidence-based recommendation for the use of ZORYVE® (roflumilast) cream 0.15% in adults with...
Company in full compliance for continued listingMIRAMAR, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the...
Initiation of patient recruitment marks a key milestone in the development of VAR 200, a potential first-in-class treatment for kidney...
PALO ALTO, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new...
UNIONDALE, NY, June 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation...
U.S. commercial rollout of novel diagnostic platform to begin second half 2025 Underserved CNS cancer diagnostic U.S. market opportunity estimated...
Attractive safety profile demonstrated across all dosing cohorts and routes of administration (IV, SC, and IM); all reported adverse events...